Korea's first clinical trial document solution 'Maven Docs' signed a use contract with LSK Global PS

JNPMEDI
02 Nov 2022 · 7 minutes read

JNPMEDI and its global clinical partner LSK Global PS announced on the 26th that they have signed a contract to use "Maven Docs," Korea's first clinical trial document preparation and management solution.

JNPMEDI and its global clinical partner LSK Global PS announced on the 26th that they have signed a contract to use "Maven Docs," Korea's first clinical trial document preparation and management solution.

JNPMEDI Launches 'Maven Docs' in Collaboration with LSK Global PS

  • JNPMEDI Launches 'Maven Docs' In Collaboration with LSK Global PS
  • LSK Global PS Contracts as a Company Using 'Maven Docs' No. 1 for Efficient Document Creation and Management
  • Maven Docs expects industry innovation through standardization of various clinical trial documentation and support for document management through data linkage.

Maven Docs is a solution that the two companies released after about a year of development through MOU signing in October last year. The solution was developed to address inefficiencies arising from frequent modifications, even though clinical trial documentation is carried out in a rigorous review and approval process.

Maven Docs standardizes the preparation of various clinical trial documents such as clinical trial plans, case records, clinical trial manuals, and consent forms, and supports simple document management through data linkage. Maven Docs' document creation function, Composer, enables easy document creation based on standardization of forms and data linkage, and can set document viewing and download rights through the function of the Viewer. It also complies with 21 CFR part 11, the FDA's regulation on electronic records and electronic signatures, providing electronic signature features optimized for clinical trials without additional program purchases.

Tags:
JNPMEDI
Maven Docs
LSK Global PS

Your Partner for a Successful Journey

JNPMEDI has been putting effort on bringing disruption on healthcare industry via integrating digital technologies to clinical research & trial operations.